文献速递腹部US

超声预测慢性乙型肝炎患者的肝脏脂肪变性

Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.
PubMed 文献 · J Ultrasound Med · 2017-02-02

单中心回顾性研究纳入2004至2014年109例接受超声和肝活检的慢性乙型肝炎患者,超声对任何脂肪变性的识别准确率为60%,超声无脂肪变性排除重度脂肪变性的特异度为100%,超声重度脂肪变性预测肝活检重度脂肪变性的准确率为89%。结论认为腹部超声可预测慢性乙型肝炎患者具有临床意义的脂肪变性。

要点

  • 超声无脂肪变性表现时,排除肝活检重度脂肪变性的特异度为100%。
  • 超声诊断重度脂肪变性预测肝活检重度脂肪变性的准确率为89%(P < .001)。
  • 超声识别任何脂肪变性在48例肝活检有脂肪变性患者中正确识别29例(60%)。

核心结论

  • 超声在识别肝活检存在脂肪变性的患者方面具有很好的准确性,腹部超声可用于预测慢性乙型肝炎患者具有临床意义的脂肪变性。

研究设计与样本

  • 单中心回顾性研究,纳入2004至2014年间所有接受超声和肝活检的非移植慢性乙型肝炎患者109例。

关键影像表现/征象

  • 超声将脂肪变性分级为无、轻度、中度或重度。
  • 超声无脂肪变性表现可排除肝活检重度脂肪变性,特异度为100%。
  • 超声重度脂肪变性预测肝活检重度脂肪变性的准确率为89%(P < .001)。
  • 超声在区分不同脂肪变性分级方面不准确。

诊断标准与关键数值

  • 肝组织学脂肪变性分级:0级 <5%;1级 <33%;2级 <66%;3级 ≥66%。
  • 重度脂肪变性定义为肝组织学分级2级或3级。
  • 超声识别任何脂肪变性在48例肝活检有脂肪变性患者中正确识别29例(60%)。
  • 超声无脂肪变性排除肝活检重度脂肪变性的特异度为100%。
  • 超声重度脂肪变性预测肝活检重度脂肪变性的准确率为89%(P < .001)。

临床应用与阅片要点

  • 超声无脂肪变性表现时,可排除肝活检重度脂肪变性,特异度为100%。
  • 超声发现重度脂肪变性时,预测肝活检重度脂肪变性的准确率为89%(P < .001)。
  • 超声在区分脂肪变性不同分级方面不准确。
  • 单变量分析中,肝活检证实的脂肪变性预测因素包括糖尿病(P < .001)、高血压(P = .03)、高胆固醇血症(P = .02)和体重指数(P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Liver inflammation and fibrosis may impair the ability of sonography to identify steatosis. We determined the accuracy of sonography in grading steatosis in patients with chronic hepatitis B compared to liver biopsy.

METHODS: We conducted was a single-center retrospective study of all nontransplanted patients with chronic hepatitis B undergoing sonography and liver biopsy between 2004 and 2014 (n = 109). Steatosis was graded by sonography as none, mild, moderate, or severe. Liver histologic analysis graded steatosis (0, <5%; 1, <33%; 2, <66%; or 3, ≥66%) and staged fibrosis (F0-F4). Severe steatosis was defined as grade 2 or 3. Clinical variables within 6 months of liver biopsy were collected, and the association with steatosis was analyzed by univariate logistic regression.

RESULTS: Patients were predominantly Asian (83%), male (62%), and hepatitis B e antigen negative (62%). Twenty-nine percent of patients were obese; 9% had diabetes mellitus; 23% had hypertension; and 31% had dyslipidemia. Forty-four percent of patients had steatosis on liver biopsy; 8% had severe steatosis. The presence of any steatosis on sonography correctly identified any steatosis on liver biopsy in 29 of 48 patients (60%). The absence of steatosis on sonography ruled out severe steatosis on biopsy (specificity, 100%). Severe steatosis on sonography correctly predicted the presence of severe steatosis on liver biopsy (89%; P < .001); however, it was not accurate at distinguishing between steatosis grades. Predictors of biopsy-proven steatosis on univariate analysis included diabetes (P < .001), hypertension (P = .03), hypercholesterolemia (P = .02), and body mass index (P < .001).

CONCLUSIONS: Sonography had excellent accuracy in identifying patients with steatosis on biopsy. Abdominal sonography can be used to predict clinically important steatosis in patients with chronic hepatitis B.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Kelly EM, Feldstein VA, Etheridge D, et al. Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B. J Ultrasound Med. 2017. PMID: 28151547. doi:10.7863/ultra.16.04076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。